Obsidian Therapeutics Inc. (OBX)
OBX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$11.99
-6.25% on the day
Market cap
$740.7M
Small cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$100.6M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | OBX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0002130606 |
| SEC industry code | Pharmaceutical Preparations |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$100.6M |
| Operating income | -$105.7M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $40.4M |
| Total assets | $88.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-08-28 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K/A | 2026-08-14 |
Source: SEC EDGAR submissions feed, 35 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.1% |
| 1 month | -27.9% |
| 3 months | Not enough price history |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -65.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| APMD | Apnimed Inc. | $17.83 | -4.29% | $742.3M |
| GYRE | Gyre Therapeutics Inc. | $6.71 | -2.26% | $748.2M |
| ANNX | Annexon Inc. | $3.83 | -3.28% | $726.1M |
| ANL | Adlai Nortye Group Ltd. | $11.76 | -17.34% | $757.0M |
| IMMX | Immix Biopharma Inc. | $8.69 | -6.05% | $720.4M |
| LXRX | Lexicon Pharmaceuticals Inc. | $1.61 | -2.42% | $716.4M |
| HELP | Helus Pharma Inc. | $10.50 | -4.80% | $767.1M |
| GERN | Geron Corporation | $1.20 | -1.64% | $771.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier